Esperion Therapeutics | ESPR - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amarin USD 48.15M 2.8M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cipla INR 32.3B 1.95B 2026-03
CSL USD 3.17B 290M 2025-12
Cytokinetics USD 24.71M 80.91M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Geron USD 12.72M 1.46M 2026-03
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Merck USD 3.86B 541M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 161M 156M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12